Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentSelling, General & AdministrativeTax ProvisionsTax RateTax Rate
Others
Shares Issued
Ratios

Atea Pharmaceuticals (AVIR) Shares Outstanding (2020 - 2022)

Atea Pharmaceuticals has reported Shares Outstanding over the past 3 years, most recently at $83.3 million for Q3 2022.

  • Quarterly results put Shares Outstanding at $83.3 million for Q3 2022, changed 0.29% from a year ago — trailing twelve months through Sep 2022 was $83.3 million (changed 0.29% YoY), and the annual figure for FY2021 was $83.1 million, up 0.81%.
  • Shares Outstanding for Q3 2022 was $83.3 million at Atea Pharmaceuticals, roughly flat from $83.3 million in the prior quarter.
  • Over the last five years, Shares Outstanding for AVIR hit a ceiling of $83.3 million in Q3 2022 and a floor of $10.1 million in Q1 2020.
  • Median Shares Outstanding over the past 3 years was $82.8 million (2021), compared with a mean of $63.1 million.
  • Biggest five-year swings in Shares Outstanding: soared 721.45% in 2021 and later grew 0.29% in 2022.
  • Atea Pharmaceuticals' Shares Outstanding stood at $82.4 million in 2020, then grew by 0.81% to $83.1 million in 2021, then increased by 0.22% to $83.3 million in 2022.
  • The last three reported values for Shares Outstanding were $83.3 million (Q3 2022), $83.3 million (Q2 2022), and $83.3 million (Q1 2022) per Business Quant data.